Logo image of FEMY

FEMASYS INC (FEMY) Stock Fundamental Analysis

NASDAQ:FEMY - Nasdaq - US31447E1055 - Common Stock - Currency: USD

1.64  -0.13 (-7.34%)

After market: 1.69 +0.05 (+3.05%)

Fundamental Rating

2

Overall FEMY gets a fundamental rating of 2 out of 10. We evaluated FEMY against 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of FEMY have multiple concerns. FEMY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

FEMY had negative earnings in the past year.
In the past year FEMY has reported a negative cash flow from operations.
FEMY had negative earnings in each of the past 5 years.
FEMY had a negative operating cash flow in each of the past 5 years.
FEMY Yearly Net Income VS EBIT VS OCF VS FCFFEMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -5M -10M

1.2 Ratios

FEMY's Return On Assets of -116.16% is on the low side compared to the rest of the industry. FEMY is outperformed by 87.23% of its industry peers.
Looking at the Return On Equity, with a value of -303.25%, FEMY is doing worse than 84.04% of the companies in the same industry.
Industry RankSector Rank
ROA -116.16%
ROE -303.25%
ROIC N/A
ROA(3y)-48.37%
ROA(5y)-65%
ROE(3y)-60.33%
ROE(5y)-97.96%
ROIC(3y)N/A
ROIC(5y)N/A
FEMY Yearly ROA, ROE, ROICFEMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

The Gross Margin of FEMY (65.83%) is better than 69.68% of its industry peers.
FEMY's Gross Margin has declined in the last couple of years.
FEMY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.76%
GM growth 5YN/A
FEMY Yearly Profit, Operating, Gross MarginsFEMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -500 -1K

More info and screens

3

2. Health

2.1 Basic Checks

FEMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
FEMY has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, FEMY has a worse debt to assets ratio.
FEMY Yearly Shares OutstandingFEMY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 5M 10M 15M 20M
FEMY Yearly Total Debt VS Total AssetsFEMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -11.37, we must say that FEMY is in the distress zone and has some risk of bankruptcy.
FEMY has a Altman-Z score of -11.37. This is amonst the worse of the industry: FEMY underperforms 80.85% of its industry peers.
FEMY has a Debt/Equity ratio of 0.85. This is a neutral value indicating FEMY is somewhat dependend on debt financing.
FEMY has a Debt to Equity ratio of 0.85. This is in the lower half of the industry: FEMY underperforms 76.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z -11.37
ROIC/WACCN/A
WACC8.39%
FEMY Yearly LT Debt VS Equity VS FCFFEMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 3.94 indicates that FEMY has no problem at all paying its short term obligations.
FEMY has a Current ratio of 3.94. This is in the better half of the industry: FEMY outperforms 69.15% of its industry peers.
A Quick Ratio of 3.26 indicates that FEMY has no problem at all paying its short term obligations.
FEMY's Quick ratio of 3.26 is fine compared to the rest of the industry. FEMY outperforms 68.62% of its industry peers.
Industry RankSector Rank
Current Ratio 3.94
Quick Ratio 3.26
FEMY Yearly Current Assets VS Current LiabilitesFEMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.35% over the past year.
Looking at the last year, FEMY shows a quite strong growth in Revenue. The Revenue has grown by 16.26% in the last year.
FEMY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.01% yearly.
EPS 1Y (TTM)17.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.69%
Revenue 1Y (TTM)16.26%
Revenue growth 3Y1.01%
Revenue growth 5YN/A
Sales Q2Q%127.46%

3.2 Future

The Earnings Per Share is expected to grow by 14.36% on average over the next years. This is quite good.
Based on estimates for the next years, FEMY will show a very strong growth in Revenue. The Revenue will grow by 129.42% on average per year.
EPS Next Y11.03%
EPS Next 2Y17.44%
EPS Next 3Y12.2%
EPS Next 5Y14.36%
Revenue Next Year132.94%
Revenue Next 2Y200.34%
Revenue Next 3Y151.48%
Revenue Next 5Y129.42%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FEMY Yearly Revenue VS EstimatesFEMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
FEMY Yearly EPS VS EstimatesFEMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FEMY. In the last year negative earnings were reported.
Also next year FEMY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FEMY Price Earnings VS Forward Price EarningsFEMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FEMY Per share dataFEMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

FEMY's earnings are expected to grow with 12.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.44%
EPS Next 3Y12.2%

More info and screens

0

5. Dividend

5.1 Amount

FEMY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FEMASYS INC

NASDAQ:FEMY (2/21/2025, 8:17:40 PM)

After market: 1.69 +0.05 (+3.05%)

1.64

-0.13 (-7.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners10.22%
Inst Owner Change-85.57%
Ins Owners7.4%
Ins Owner Change0%
Market Cap37.56M
Analysts82
Price Target8.41 (412.8%)
Short Float %0.68%
Short Ratio0.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.21%
Min EPS beat(2)-18.78%
Max EPS beat(2)-17.65%
EPS beat(4)2
Avg EPS beat(4)-2.95%
Min EPS beat(4)-18.78%
Max EPS beat(4)12.34%
EPS beat(8)4
Avg EPS beat(8)-3%
EPS beat(12)6
Avg EPS beat(12)3.68%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-44.46%
Min Revenue beat(2)-72.34%
Max Revenue beat(2)-16.58%
Revenue beat(4)0
Avg Revenue beat(4)-41.62%
Min Revenue beat(4)-72.34%
Max Revenue beat(4)-11.8%
Revenue beat(8)1
Avg Revenue beat(8)-27.66%
Revenue beat(12)3
Avg Revenue beat(12)-16.76%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-4.23%
EPS NQ rev (3m)-4.23%
EPS NY rev (1m)-0.94%
EPS NY rev (3m)-6.64%
Revenue NQ rev (1m)-5.72%
Revenue NQ rev (3m)10.02%
Revenue NY rev (1m)-0.94%
Revenue NY rev (3m)8.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 29.79
P/FCF N/A
P/OCF N/A
P/B 6.29
P/tB 6.37
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0.06
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -116.16%
ROE -303.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.83%
FCFM N/A
ROA(3y)-48.37%
ROA(5y)-65%
ROE(3y)-60.33%
ROE(5y)-97.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.76%
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 254.8%
Cap/Sales 62.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.94
Quick Ratio 3.26
Altman-Z -11.37
F-Score3
WACC8.39%
ROIC/WACCN/A
Cap/Depr(3y)51.84%
Cap/Depr(5y)54.57%
Cap/Sales(3y)24.53%
Cap/Sales(5y)30.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.69%
EPS Next Y11.03%
EPS Next 2Y17.44%
EPS Next 3Y12.2%
EPS Next 5Y14.36%
Revenue 1Y (TTM)16.26%
Revenue growth 3Y1.01%
Revenue growth 5YN/A
Sales Q2Q%127.46%
Revenue Next Year132.94%
Revenue Next 2Y200.34%
Revenue Next 3Y151.48%
Revenue Next 5Y129.42%
EBIT growth 1Y-34.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-72.16%
OCF growth 3YN/A
OCF growth 5YN/A